Acetaminophen Recent News
December 19, 2006: FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers
The U.S. Food and Drug Administration (FDA) proposed to amend the labeling regulations on over-the-counter pain relievers, to include important safety information about the potential for stomach bleeding and liver damage. For products containing acetaminophen, the FDA proposed new warnings highlighting the risk of liver toxicity, and suggested that the ingredient acetaminophen be prominently displayed on the product's immediate container and on the outer carton (if applicable). Click here to read more from the FDA.
November 9, 2006:Perrigo Company Issues Voluntary Recall on Acetaminophen Caplets
Perrigo Company issued a recall for 383 lots ofacetaminophen 500 mg caplets manufactured and distributed under variousstore-brands as a result of small metal fragments found in a small number ofthese caplets. Approximately 11 millionbottles containing varying quantities of acetaminophen 500 mg caplets areaffected by this recall. As of the time of the recall, no illnesses, injuries, orconsumer complaints had been reported. Moreinformation:
- Recall Information from the Perrigo Company
- FDA News Release on the Recall (includes affected stores and products)
February 3, 2006: ConsumerGroup Warns About Potentially Fatal Liver Failure
In a posting on its website, national non-profit consumeradvocacy Public Citizen writes that acetaminophen is linked to a large increasein cases of potentially fatal liver failure. In 2003, the FDA similarly urged consumers to exercise caution whenusing acetaminophen, cautioning that ingestion of too much of the painkiller couldlead to serious liver damage. More information: